100 related articles for article (PubMed ID: 15735694)
1. Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.
Fedele M; Pentimalli F; Baldassarre G; Battista S; Klein-Szanto AJ; Kenyon L; Visone R; De Martino I; Ciarmiello A; Arra C; Viglietto G; Croce CM; Fusco A
Oncogene; 2005 May; 24(21):3427-35. PubMed ID: 15735694
[TBL] [Abstract][Full Text] [Related]
2. The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
Hillion J; Dhara S; Sumter TF; Mukherjee M; Di Cello F; Belton A; Turkson J; Jaganathan S; Cheng L; Ye Z; Jove R; Aplan P; Lin YW; Wertzler K; Reeves R; Elbahlouh O; Kowalski J; Bhattacharya R; Resar LM
Cancer Res; 2008 Dec; 68(24):10121-7. PubMed ID: 19074878
[TBL] [Abstract][Full Text] [Related]
3. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
4. An XBP1s-PIM-2 positive feedback loop controls IL-15-mediated survival of natural killer cells.
Ma S; Han J; Li Z; Xiao S; Zhang J; Yan J; Tang T; Barr T; Kraft AS; Caligiuri MA; Yu J
Sci Immunol; 2023 Mar; 8(81):eabn7993. PubMed ID: 36897958
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Models of Neuroendocrine Neoplasia.
Sedlack AJH; Saleh-Anaraki K; Kumar S; Ear PH; Lines KE; Roper N; Pacak K; Bergsland E; Quelle DE; Howe JR; Pommier Y; Del Rivero J
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428741
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of HMGA2 by Small Interfering RNA Affects the Survival, Migration, and Apoptosis of Prostate Cancer Cell Line.
Khajouee S; Baghbani E; Mohammadi A; Mansoori B; Shanehbandi D; Hajiasgharzadeh K; Baradaran B
Adv Pharm Bull; 2022 Mar; 12(2):398-403. PubMed ID: 35620335
[No Abstract] [Full Text] [Related]
7. Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications.
Biagetti B; Simò R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681905
[TBL] [Abstract][Full Text] [Related]
8. Critical role of the high mobility group A proteins in hematological malignancies.
De Martino M; Esposito F; Fusco A
Hematol Oncol; 2022 Feb; 40(1):2-10. PubMed ID: 34637548
[TBL] [Abstract][Full Text] [Related]
9. HMGA1 induces EZH2 overexpression in human B-cell lymphomas.
De Martino M; Nicolau-Neto P; Ribeiro Pinto LF; Traverse-Glehen A; Bachy E; Gigantino V; De Cecio R; Bertoni F; Chieffi P; Fusco A; Esposito F
Am J Cancer Res; 2021; 11(5):2174-2187. PubMed ID: 34094676
[TBL] [Abstract][Full Text] [Related]
10. HMGA1 Is a Potential Driver of Preeclampsia Pathogenesis by Interference with Extravillous Trophoblasts Invasion.
Matsubara K; Matsubara Y; Uchikura Y; Takagi K; Yano A; Sugiyama T
Biomolecules; 2021 May; 11(6):. PubMed ID: 34072941
[TBL] [Abstract][Full Text] [Related]
11. Identification of potential and novel target genes in pituitary prolactinoma by bioinformatics analysis.
Ghatnatti V; Vastrad B; Patil S; Vastrad C; Kotturshetti I
AIMS Neurosci; 2021; 8(2):254-283. PubMed ID: 33709028
[TBL] [Abstract][Full Text] [Related]
12. Genetic and Epigenetic Causes of Pituitary Adenomas.
Chang M; Yang C; Bao X; Wang R
Front Endocrinol (Lausanne); 2020; 11():596554. PubMed ID: 33574795
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Vascular Smooth Muscle Cell Phenotype by High Mobility Group AT-Hook 1.
Jung Y; Lee HS; Ha JM; Jin SY; Kum HJ; Vafaeinik F; Ha HK; Song SH; Kim CD; Bae SS
J Lipid Atheroscler; 2021 Jan; 10(1):99-110. PubMed ID: 33537257
[TBL] [Abstract][Full Text] [Related]
14. HMGA1 Induction of miR-103/107 Forms a Negative Feedback Loop to Regulate Autophagy in MPTP Model of Parkinson's Disease.
Li G; Luo W; Wang B; Qian C; Ye Y; Li Y; Zhang S
Front Cell Neurosci; 2020; 14():620020. PubMed ID: 33536877
[TBL] [Abstract][Full Text] [Related]
15. Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?
Asa SL; Mete O; Ezzat S
Endocr Pathol; 2021 Mar; 32(1):3-16. PubMed ID: 33433883
[TBL] [Abstract][Full Text] [Related]
16. Interplay between HMGA and TP53 in cell cycle control along tumor progression.
Meireles Da Costa N; Palumbo A; De Martino M; Fusco A; Ribeiro Pinto LF; Nasciutti LE
Cell Mol Life Sci; 2021 Feb; 78(3):817-831. PubMed ID: 32920697
[TBL] [Abstract][Full Text] [Related]
17. HMGA Proteins in Hematological Malignancies.
Minervini A; Coccaro N; Anelli L; Zagaria A; Specchia G; Albano F
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32503270
[TBL] [Abstract][Full Text] [Related]
18. HMGA1-Regulating microRNAs Let-7a and miR-26a are Downregulated in Human Seminomas.
De Martino M; Esposito F; Pellecchia S; Cortez Cardoso Penha R; Botti G; Fusco A; Chieffi P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344629
[TBL] [Abstract][Full Text] [Related]
19. RPSAP52 lncRNA Inhibits p21Waf1/CIP Expression by Interacting With the RNA Binding Protein HuR.
D'Angelo D; Arra C; Fusco A
Oncol Res; 2020 Mar; 28(2):191-201. PubMed ID: 31831098
[TBL] [Abstract][Full Text] [Related]
20. Emerging Role of USP8, HMGA, and Non-Coding RNAs in Pituitary Tumorigenesis.
D'Angelo D; De Martino M; Arra C; Fusco A
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31487906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
